BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
81 results:

  • 1. [Minimally Invasive Conversion Hepatectomy for Advanced Hepatocellular Carcinoma].
    Sakai H; Goto Y; Shimose S; Niizeki T; Kawaguchi T; Akiba J; Yano H; Akagi Y; Fujita F; Hisaka T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1572-1574. PubMed ID: 38303345
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Measurement of Trogocytosis: Quantitative Analyses Validated with Rigorous Controls.
    Taylor RP; Lindorfer MA
    Curr Protoc; 2023 Oct; 3(10):e897. PubMed ID: 37830752
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis.
    Shen Z; Cai J; Tao L; Zheng J; Ye Z; Liu Y; Pan H; Wang Y; Xu J; Liang X
    Cancer Gene Ther; 2023 Dec; 30(12):1663-1678. PubMed ID: 37828105
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
    Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
    Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
    Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
    Tsumura S; Shimose S; Niizeki T; Kuboyama E; Iwamoto H; Tanaka M; Moriyama E; Shirono T; Takaki K; Noda Y; Nakano M; Inoue M; Tsustumi K; Kuromatsu R; Koga H; Higuchi K; Kawaguchi T
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1140-1147. PubMed ID: 36880677
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.
    Iwamoto H; Shimose S; Shirono T; Niizeki T; Kawaguchi T
    Clin Mol Hepatol; 2023 Jul; 29(3):593-604. PubMed ID: 36775834
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC.
    Kondo Y; Morosawa T; Minami S; Tanaka Y
    Sci Rep; 2022 Oct; 12(1):16868. PubMed ID: 36207618
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A Case of Combined Modality Therapy for Progressive Esophagus cancer with Perforation Due to Preoperative Chemotherapy].
    Miyoshi K; Ota Y; Sakurai T; Matsumoto M; Yamada E; Enomoto M; Iwasaki K; Nagakawa Y; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2022 Jan; 49(1):77-79. PubMed ID: 35046367
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated liver Disease.
    Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
    Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Usefulness of a novel transarterial chemoinfusion plus external-beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right atrium: Case study.
    Shirono T; Koga H; Niizeki T; Nagamatsu H; Iwamoto H; Shimose S; Nakano M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Ogo E; Torimura T
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1539. PubMed ID: 34431232
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H; Chi JC; Liu R; Zhai B
    Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [A Case in Which Multiple Post-Operatively Recurring Hepatocellular Carcinomas Showed a Positive Response to Sorafenib-Hepatic Arterial Infusion Chemotherapy (HAIC)Sequential Therapy].
    Iwata N; Ishii Y; Yoshida Y; Kikuchi T; Mita H; Adachi Y; Adachi Y; Minami T; Ikeda K; Makiguchi Y; Hata F; Kato Y; Endo T
    Gan To Kagaku Ryoho; 2021 Feb; 48(2):215-218. PubMed ID: 33597362
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Jianpi Yiqi Shexue ameliorates immune thrombocytopenia related fatigue by regulating mitochondrial function.
    Zhang Y; Wang J; Gao J; Guo M; Chen H; Liu J; Li L; Liao J; Chen X; Lang H
    Ann Palliat Med; 2021 Jan; 10(1):156-168. PubMed ID: 33440960
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal cancer Models through Distinct Mechanistic and Pharmacologic Properties.
    Gmeiner WH; Dominijanni A; Haber AO; Ghiraldeli LP; Caudell DL; D'Agostino R; Pasche BC; Smith TL; Deng Z; Kiren S; Mani C; Palle K; Brody JR
    Mol Cancer Ther; 2021 Mar; 20(3):553-563. PubMed ID: 33361273
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the liverT study.
    Miksad RA; Ogasawara S; Xia F; Fellous M; Piscaglia F
    BMC Cancer; 2019 Aug; 19(1):795. PubMed ID: 31409405
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS/NFκB signaling.
    Li J; Liang N; Long X; Zhao J; Yang J; Du X; Yang T; Yuan P; Huang X; Zhang J; He X; Xing J
    Cancer Lett; 2019 Oct; 461():44-55. PubMed ID: 31278950
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
    Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
    Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
    He X; Wu J; Holtorf AP; Rinde H; Xie S; Shen W; Hou J; Li X; Li Z; Lai J; Wang Y; Zhang L; Wang J; Li X; Ma K; Ye F; Ouyang H; Zhao H
    PLoS One; 2018; 13(1):e0191095. PubMed ID: 29324837
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.
    Fidler MM; Gupta S; Soerjomataram I; Ferlay J; Steliarova-Foucher E; Bray F
    Lancet Oncol; 2017 Dec; 18(12):1579-1589. PubMed ID: 29111259
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.